1832 Asset Management’s ResMed RMD Stock Holding History

1832 Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.23M	Sell	26,857 -10,316	-28%	-$2.14M	﹤0.01%	426
2026 Q1	$8.34M	Sell	37,173 -149	-0.4%	-$37.1K	0.01%	380
2025 Q4	$8.99M	Sell	37,322 -297	-0.8%	-$76K	0.01%	374
2025 Q3	$10.3M	Sell	37,619 -1,890	-5%	-$516K	0.01%	331
2025 Q2	$10.2M	Buy	39,509 +14,030	+55%	+$3.35M	0.01%	323
2025 Q1	$5.7M	Sell	25,479 -170	-0.7%	-$39.7K	0.01%	369
2024 Q4	$5.87M	Sell	25,649 -4,041	-14%	-$973K	0.01%	363
2024 Q3	$7.25M	Buy	29,690 +10	+0%	+$2.23K	0.01%	368
2024 Q2	$5.68M	Sell	29,680 -4,567	-13%	-$927K	﹤0.01%	373
2024 Q1	$6.78M	Buy	+34,247	New	+$6.28M	﹤0.01%	355
2021 Q4	–	Sell	-1,046	Closed	-$279K	–	847
2021 Q3	$279K	Buy	+1,046	New	+$286K	﹤0.01%	627

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

1832 Asset Management's RMD Position: Q2 2026 in Review

1832 Asset Management reduced its ResMed (RMD) stake by 28% in Q2 2026, selling an estimated $2.14M and leaving 26,857 shares worth $5.23M. The position accounts for ﹤0.01% of the portfolio, ranked #426.

1832 Asset Management first reported a position in RMD in Q3 2021 and has held it in 11 quarters since. The position peaked at $10.3M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

1832 Asset Management held 26,857 shares of ResMed worth $5.23M as of Q2 2026.
1832 Asset Management sold 10,316 ResMed shares in Q2 2026, an estimated $2.14M.
ResMed made up ﹤0.01% of 1832 Asset Management's portfolio in Q2 2026, its #426 holding.
1832 Asset Management first reported a position in ResMed in Q3 2021 and has held it in 11 quarters since.
1832 Asset Management's ResMed position peaked at $10.3M in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on 1832 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.